Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test December 8, 2020December 9, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailQuantifying IgG is critical component to test population-wide vaccination effectiveness Related News: Thermo Fisher Scientific Earns NSF/ANSI 456 Vaccine…Molecular Devices launches automated workcells for…Roche to launch SARS-CoV-2 & Flu A/B Rapid…Roche to introduce its next-generation portfolio of…Notice Concerning Recording of Extraordinary Gains…Xylem Appoints Mark Morelli to Board of Directors
